Drawing for OFD LIFE SCIENCES

USPTO serial 99338601

OFD LIFE SCIENCES

Reviewed by CopyMark Law Group

Status 649Office Action
Filing date
Status date
Registration date
—
Examiner
SUK, HAE P
Law office
TMEG LAW OFFICE 107

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Need help with OFD LIFE SCIENCES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

ERNEST G. BOOTSMA

Ernest G. Bootsma Buchalter, PC805 S.W. Broadway, Suite 1500Portland, OR 97205United States

Goods and services

ClassDescriptionStatusFirst use
005Freeze-dried compounds in the nature of active pharmaceutical ingredients, biologicals for pharmaceuticals, nonfood articles and food products adapted for medical purposes; Drug delivery agents in the form of capsules, powders, tablets, intra-nasal spray, intra-nasal mist, dissolvable films, transdermal patches, and pastilles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules, powders, tablets, intra-nasal spray, intra-nasal mist, dissolvable films, transdermal patches and pastilles that facilitate the delivery of pharmaceutical preparationsACTIVEOct 25, 2024
040Custom manufacture of pharmaceuticals; Custom manufacture of biopharmaceuticals; custom freeze drying and preservation for others of pharmaceutical ingredients, biologicals for pharmaceuticals, nonfood articles, and food products for use by pharmaceutical, medical, biotechnology, and research industry companies; consulting services in the field of freeze drying pharmaceutical ingredients, biologicals for pharmaceuticals, nonfood articles, and food products; material transformation services, namely, freeze drying compounds in the nature of active pharmaceutical ingredients and biologicals for pharmaceuticals and nonfood articles; material transformation services, namely, freeze drying food products and nonfood articles; advice and information regarding lyophilization servicesACTIVEOct 25, 2024
042Custom design and engineering of freeze dried pharmaceutical ingredients, biologicals for pharmaceuticals, nonfood articles, and food products for use by pharmaceutical, medical, biotechnology, and research industry companiesACTIVEOct 25, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 4, 2026GEA1NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED—
Nov 4, 2026GECDACTION DENYING REQ FOR RECON E-MAILED—
Nov 4, 2026CNCFACTION CONTINUING FINAL - COMPLETED—
Sep 3, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 3, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 2, 2026ALIEASSIGNED TO LIE—
Sep 1, 2026ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Sep 1, 2026EXPIEX PARTE APPEAL-INSTITUTED—
Sep 1, 2026JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Sep 1, 2026EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Jun 1, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jun 1, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 1, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 20, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 20, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 20, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 20, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 20, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 20, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 31, 2025DOCKASSIGNED TO EXAMINER—
Dec 30, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 14, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 14, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance